Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023
Current Psychiatry Reports · 2024
DOI: 10.1007/s11920-024-01494-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Psychiatry Reports, 2024. Verfasst von John L Havlik und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yale University School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Electroconvulsive Therapy, Depressive Disorder, Treatment-Resistant. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.
Themen: Depression
Abstract (Originalsprache)
PURPOSE OF REVIEW: We review recent advances in the treatment of treatment-resistant depression (TRD), a disorder with very limited treatment options until recently. We examine advances in psychotherapeutic, psychopharmacologic, and interventional psychiatry approaches to treatment of TRD. We also highlight various definitions of TRD in recent scientific literature. RECENT FINDINGS: Recent evidence suggests some forms of psychotherapy can be effective as adjunctive treatments for TRD, but not as monotherapies alone. Little recent evidence supports the use of adjunctive non-antidepressant pharmacotherapies such as buprenorphine and antipsychotics for the treatment of TRD; side effects and increased medication discontinuation rates may outweigh the benefits of these adjunctive pharmacotherapies. Finally, a wealth of recent evidence supports the use of interventional approaches such as electroconvulsive therapy, ketamine/esketamine, and transcranial magnetic stimulation for TRD. Recent advances in our understanding of how to treat TRD have largely expanded our knowledge of best practices in, and efficacy of, interventional psychiatric approaches. Recent research has used a variety of TRD definitions for study inclusion criteria; research on TRD should adhere to inclusion criteria based on internationally defined guidelines for more meaningfully generalizable results.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Yale University School of Medicine, New Haven, CT, USA.
- The University of Chicago, Chicago, IL, USA.
- Brain and Cognition Discovery Foundation, Toronto, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada.
- Department of Pharmacology, University of Toronto, Toronto, Canada.
- Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Förderung
- NIA NIH HHS
Zitieren
APA
Havlik, J. L., Wahid, S., Teopiz, K. M., McIntyre, R. S., Krystal, J. H., & Rhee, T. G. (2024). Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023. Current Psychiatry Reports. https://doi.org/10.1007/s11920-024-01494-4
Vancouver
Havlik JL, Wahid S, Teopiz KM, McIntyre RS, Krystal JH, Rhee TG. Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023. Current Psychiatry Reports. 2024. doi:10.1007/s11920-024-01494-4
BibTeX
@article{Havlik2024,
author = {Havlik, John L and Wahid, Syed and Teopiz, Kayla M and McIntyre, Roger S and Krystal, John H and Rhee, Taeho Greg},
title = {Recent Advances in the Treatment of Treatment-Resistant Depression: A Narrative Review of Literature Published from 2018 to 2023},
journal = {Current Psychiatry Reports},
year = {2024},
doi = {10.1007/s11920-024-01494-4}
}
EUVIMED